Novo Nordisk CEO on 2026 Forecast and GLP-1 Pricing
Novo Nordisk CEO Mike Doustdar discusses the company’s updated 2026 sales guidance, forecasting a decline of 5 to 13% at…
Tag: GLP1
Novo Nordisk CEO talks GLP-1 pill at JPMorgan conference
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to…
Dr. Drew Says GLP-1 Drugs May Have Helped Nick Reiner, But It’s Delicate Balance
Dr. Drew On Nick Reiner GLP-1s Could Have Prevented Murders Published January 12, 2026 12:40 PM PST Play video content…
Americold Realty Trust (COLD) Traded Down Due to the Popularity of GLP-1 Drugs
American Century Investments, an investment management company, released its third-quarter 2025 investor letter for the “American Century Investments Small Cap…
First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of…
Oprah Reveals Use of GLP-1 Medications Led to Sobriety
Oprah Winfrey is feeling better than ever. While the media mogul has been candid about her use of GLP-1s for weight…
Wegovy-maker Novo Nordisk shares surge after GLP-1 pill approval
Shares in Novo Nordisk surged 6% Monday, after the Wegovy maker secured approval of its GLP-1 pill — a world…
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of…
Weight Watchers Is Going All In on GLP-1 Drugs. Should You Buy WW Stock Here?
WW International (WW), more commonly known as Weight Watchers, is fully embracing GLP-1 weight-loss drugs, such as Ozempic and Wegovy,…
WHO recommends GLP-1 for treating obesity. What is it?
The World Health Organisation on Monday conditionally recommended the use of GLP-1 therapies as part of long-term treatment for obesity,…